Core Insights - Michael J. Kent of Kent | Pincin has been recognized as a Super Lawyer for 2026, highlighting his outstanding legal achievements and peer recognition within the legal community [1][5][7] Company Overview - Kent | Pincin is dedicated to excellence in legal services, focusing on client advocacy and professional integrity, particularly in employment law and personal injury cases [2][10] - The firm is co-founded by Emily Rose Pincin, who plays a significant role in shaping its practice and commitment to client service [2][10] Practice Areas - The firm specializes in employment law and discrimination in California, addressing complex workplace issues with a strong understanding of state regulations [3][8] - Kent | Pincin is also recognized for its work in personal injury cases in Redondo Beach, advocating for clients harmed by negligence or accidents [4][8] Commitment to Legal Excellence - The recognition of Michael J. Kent as a Super Lawyer underscores the professionalism and strength of the Kent | Pincin team, reinforcing the firm's reputation as a trusted advocate [5][7] - Kent | Pincin emphasizes high-quality legal services without promotional claims, focusing on straightforward and effective representation for clients [6][8]

Core Viewpoint - Rosen Law Firm is urging investors of WPP plc to secure legal counsel before the December 8, 2025 deadline for a securities class action lawsuit related to the purchase of American Depositary Shares (ADS) during the specified class period [2][3]. Group 1: Class Action Details - The class period for the WPP ADSs is from February 27, 2025, to July 8, 2025, inclusive [2]. - Investors who purchased WPP ADSs during this period may be eligible for compensation without incurring out-of-pocket fees through a contingency fee arrangement [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - The Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [5]. Group 3: Case Allegations - The complaint alleges that WPP provided misleading positive statements while concealing adverse facts about its media arm's ability to handle macroeconomic challenges, leading to a loss of market share [6]. - The lawsuit claims that when the true state of affairs became known, investors suffered damages [6].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of America's Car-Mart, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Legal Action - Shareholders who purchased America's Car-Mart, Inc. securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses [2]. Group 2: Company Performance and Market Reaction - On September 4, 2025, America's Car-Mart, Inc. reported a first-quarter loss of 69 cents per share, compared to a net loss of 15 cents per share in the same period the previous year [3]. - Following the release of these results, America's Car-Mart, Inc. stock experienced a significant decline of 18.2% on the same day [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [4].

Core Viewpoint - Rosen Law Firm is reminding investors of Sina Corporation to secure counsel before the November 18, 2025 deadline for a securities class action related to the merger that occurred between October 13, 2020, and March 22, 2021 [1][2]. Group 1: Class Action Details - Investors who sold ordinary shares during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by November 18, 2025 [3]. - The lawsuit alleges that defendants created a fraudulent scheme to depress the value of Sina's shares to avoid paying a fair price during the merger [5]. Group 2: Allegations Against Defendants - The defendants are accused of misrepresenting and omitting material information in Sina's proxy materials, which were necessary for shareholders to make informed decisions regarding the merger [5]. - Specific allegations include the concealment of the true value of Sina's investment in TuSimple and that the merger offer of $43.30 per share significantly undervalued Sina's ordinary shares [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Synopsys, Inc. securities between December 4, 2024, and September 9, 2025, of the December 30, 2025, lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Synopsys securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6] - The lead plaintiff must file a motion with the Court by December 30, 2025, to represent other class members in the litigation [3] Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4] - The firm has secured significant settlements for investors, including over $438 million in 2019 and has been ranked highly for its performance in securities class action settlements [4] Group 3: Case Allegations - The lawsuit alleges that Synopsys made materially false and misleading statements and failed to disclose adverse facts about its business and operations during the Class Period [5] - Specific claims include the negative impact of Synopsys' focus on artificial intelligence customers on its Design IP business and the misleading nature of the company's positive statements regarding its prospects [5]

Core Viewpoint - Rosen Law Firm is encouraging investors of Jasper Therapeutics, Inc. to secure legal counsel before the November 18, 2025 deadline for a securities class action lawsuit related to the company's stock performance during the specified class period [1][2]. Group 1: Class Action Details - Investors who purchased Jasper Therapeutics securities between November 30, 2023, and July 3, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by November 18, 2025 [3][6]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Allegations Against Jasper Therapeutics - The lawsuit alleges that Jasper Therapeutics made false and misleading statements regarding its manufacturing controls and compliance with cGMP regulations, which could negatively impact the clinical and commercial prospects of its products, including briquilimab [5]. - The failure to disclose these issues allegedly increased the risk of confounding study results and the likelihood of disruptive cost-reduction measures, leading to an overstatement of the company's business and financial prospects [5].

Core Viewpoint - Rosen Law Firm is reminding investors of Molina Healthcare, Inc. about an important deadline related to a securities class action lawsuit, encouraging them to secure legal counsel before December 2, 2025 [1][3]. Group 1: Class Action Details - Investors who purchased Molina securities between February 5, 2025, and July 23, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and potential lead plaintiffs must act by December 2, 2025 [3]. - The lawsuit alleges that Molina failed to disclose several material adverse facts regarding its financial health and operational assumptions, which misled investors [5]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of successful settlements in securities class actions, having recovered hundreds of millions of dollars for investors [4]. Group 3: Case Specifics - The lawsuit claims that Molina's financial guidance for fiscal year 2025 was likely to be cut due to undisclosed issues related to medical cost trends and service utilization [5]. - The misleading statements made by Molina regarding its business operations and prospects are central to the claims made in the lawsuit [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of James Hardie Industries plc to secure legal counsel before the December 23, 2025 deadline for a securities class action lawsuit related to misleading statements about the company's performance during a specific period [2][4]. Group 1: Class Action Details - The class action pertains to investors who purchased common stock of James Hardie between May 20, 2025, and August 18, 2025, and may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3][6]. - A lawsuit claims that James Hardie misled investors regarding the strength of its North America Fiber Cement segment, falsely asserting that demand was strong while distributors were actually destocking inventory [6]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Inspire Medical Systems, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [2][4]. Group 1: Class Action Details - Investors who bought Inspire Medical common stock between August 6, 2024, and August 4, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 5, 2026 [4][6]. - The lawsuit alleges that Inspire Medical misrepresented key facts about its sleep apnea device, Inspire V, including market demand and necessary steps for its launch, leading to investor damages when the truth was revealed [6]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [5]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [5].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of investors who purchased Freeport-McMoRan Inc. securities between February 15, 2022, and September 24, 2025, alleging misleading statements and safety issues at the Grasberg Block Cave mine in Indonesia [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Freeport-McMoRan did not adequately ensure safety at its Grasberg Block Cave mine, leading to heightened risks for workers [5]. - The lawsuit alleges that the company's statements regarding its business operations and prospects were materially false and misleading due to undisclosed risks [5]. - Investors who purchased securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Next Steps for Investors - Investors wishing to join the class action must move the Court by January 12, 2026, to serve as lead plaintiff [1][3]. - Interested parties can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - It is noted that no class has been certified yet, and investors are encouraged to select qualified counsel [4][6]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized as a leader in the field, ranked No. 1 for securities class action settlements in 2017 and consistently in the top 4 since 2013 [4]. - The founding partner has received accolades, including being named a Titan of Plaintiffs' Bar by Law360 in 2020 [4].